To use all functions of this page, please activate cookies in your browser.
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Docosanol
Docosanol, also known as behenyl alcohol, is a saturated fatty alcohol used mainly as an antiviral agent, specifically for treatment of "cold sores" caused by the herpes simplex virus. It is normally administered topically in a cream containing a base and a 10% mix of the active ingredient. Additional recommended knowledgeIt functions by inhibiting the fusion of the human host cell with the viral envelope of the herpes virus, thus preventing its replication. Docosanol was approved for use after clinical trials by the FDA in July 2000.[1] Marketed by Avanir Pharmaceuticals under the brand name Abreva, it was the first over-the-counter antiviral drug approved for sale in the United States and Canada. In March, 2007 it was the subject of a US nationwide class-action suit against Avanir and GlaxoSmithKline as the claim that it cut recovery times in half was found to have been misleading in a California court.[2] See alsoReferences
Categories: Antivirals | Fatty alcohols |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Docosanol". A list of authors is available in Wikipedia. |